Last reviewed: July 17, 2026
Last updated: July 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide (brand name Mounjaro) works by activating two hormone receptors that control hunger and blood sugar, requiring a carefully stepped approach to dosing rather than a one-size-fits-all calculation. Your starting dose, progression timeline, and target dose depend on your individual tolerance, medical history, and weight loss goals. PlexusDx prescribes compounded tirzepatide injections from licensed 503A pharmacies, with pricing that remains flat regardless of dose level.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Understanding Tirzepatide Dosing Progression
Tirzepatide dosing follows a step-up protocol rather than a formula-based calculation. Most treatment plans start with a 2.5 mg weekly injection, held for 4 weeks to assess tolerance and side effects. After that initial month, your clinician evaluates your response and may increase to 5 mg, then 7.5 mg, and potentially up to 15 mg per week, with each dose held for 4 weeks before advancing. This gradual increase allows your body to adapt and helps minimize nausea, constipation, and other common effects.
The reason for stepped dosing is that tirzepatide's dual action on GLP-1 and GIP receptors produces dose-dependent effects on appetite suppression and metabolic rate. Research shows that most patients experience meaningful weight loss at doses between 7.5 mg and 15 mg weekly, though individual variation is significant. Your healthcare provider adjusts timing based on tolerability—some patients move faster through dose tiers, while others benefit from staying at intermediate doses longer to maximize results with fewer side effects.
Factors That Shape Your Tirzepatide Dose
Several clinical factors influence where your dose will stabilize. Your starting weight, baseline metabolic rate, kidney and liver function, concurrent medications, and history of gastrointestinal issues all inform your prescriber's decisions. Patients with advanced kidney disease may require dose modifications, while those with a history of thyroid cancer or medullary thyroid carcinoma cannot use tirzepatide at all. Your prescriber reviews your medical records and lab work to confirm tirzepatide is safe for you before initiating therapy.
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How PlexusDx Personalizes Your Tirzepatide Treatment
PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan and remain at that flat price regardless of your dose level—a commitment to transparent, predictable healthcare. Your dose may need to go up. Your price won't. All medications come from licensed 503A compounding pharmacies, verified for sterility, potency, and purity, and PlexusDx serves all 50 states without requiring insurance or membership fees.
When you enroll with PlexusDx, a clinical team member reviews your health history, current medications, and weight loss goals to recommend a starting dose and timeline. You receive detailed instructions for weekly self-injection, side effect management, and when to contact your provider. After your first month of treatment, you're eligible to add the Precision Peptide Genetic Test ($99), which maps 14 peptide-related pathways and 49 genetic markers to confirm tirzepatide is aligned with your biology or suggest alternative compounds like compounded semaglutide if your genetic profile suggests better outcomes.
Monitoring Progress and Adjusting Your Dose
Your tirzepatide dose adjustments are guided by weight loss progress, side effect tolerance, and clinical judgment, not by a predetermined schedule. Typically, your provider schedules a check-in 4 weeks after starting or after each dose increase to review your weight, any adverse effects, and appetite changes. If you're experiencing mild nausea or constipation but losing weight steadily, your provider may hold your current dose longer before advancing. Conversely, if you tolerate the dose well and plateau for 2–3 weeks, moving to the next dose tier may accelerate results.
PlexusDx coordinates your follow-up appointments via secure messaging or phone consultations, eliminating the need for repeated office visits. Your prescriber documents your response pattern, which becomes valuable information if you ever need to adjust course—such as temporarily reducing your dose if side effects become intolerable, or switching to an alternative compound like GLP-Squared (a dual tirzepatide-semaglutide blend) if you're seeking different efficacy or tolerability.
Cost Transparency and HSA/FSA Eligibility
PlexusDx tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan on the lowest commitment tier, with options for 3-month or annual prepayment that may offer modest additional savings. This flat-rate pricing is designed to remove the financial guesswork—you know your monthly cost upfront, and it doesn't increase as your dose climbs from 2.5 mg to 15 mg. HSA and FSA funds are accepted, allowing you to use pre-tax dollars if you have an eligible health plan.
Unlike traditional pharmacies, PlexusDx compounded medications are not covered by standard insurance because they are custom-formulated, not brand-name drugs. However, the absence of insurance requirements means no prior authorizations, no coverage denials, and no waiting periods. You pay out-of-pocket at a transparent rate, avoiding the unpredictability of copays and deductibles that often surround branded GLP-1 therapies.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I calculate my tirzepatide dose myself before starting treatment?
No—tirzepatide dosing cannot be self-calculated because it depends on your unique medical history, tolerance, and clinical response rather than a weight-based formula. PlexusDx clinicians review your health profile to recommend a safe starting dose (typically 2.5 mg), then adjust based on how your body responds over weeks, not a predetermined equation.
What is the typical tirzepatide dose range for weight loss?
Most patients see meaningful weight loss at tirzepatide doses between 7.5 mg and 15 mg weekly, though some respond well at lower doses. Clinical trials show that patients on 15 mg achieved an average 20–22% body weight reduction, while those on 10 mg averaged 16–18% reduction. Your optimal dose depends on your genetics, tolerability, and individual metabolism.
How much does tirzepatide cost at PlexusDx?
PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan on a monthly commitment plan, with discounted rates for 3-month and annual prepayment. Your price stays flat regardless of dose increases—whether you're taking 2.5 mg or 15 mg weekly, you pay the same monthly rate.
Are there serious side effects with tirzepatide dosing?
Common side effects include nausea, constipation, vomiting, and appetite loss, most mild to moderate and occurring early in treatment. Serious but rare risks include pancreatitis, severe dehydration, and thyroid concerns; tirzepatide is contraindicated if you have medullary thyroid carcinoma or thyroid cancer history. PlexusDx clinicians screen for contraindications and monitor your safety throughout treatment.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Starting Line: What is the Lowest Dose on Mounjaro and Your Weight Loss Journey
Zepbound Storage Essentials: Can You Take Zepbound Right Out of the Fridge?